
SORAFENIB 200 mg (Soranib) is a prescription targeted anticancer medicine used to treat advanced liver cancer, also known as hepatocellular carcinoma, advanced kidney cancer, and radioactive iodine-refractory differentiated thyroid cancer. It belongs to a class of medicines called multikinase inhibitors and helps slow the growth and spread of cancer by blocking proteins involved in tumour growth and blood vessel formation.
| Generic name | SORAFENIB |
| Strength | 200 mg |
| Manufacturer | CIPLA |
| Package size | 120 Tablets |
| Used for | Advanced liver cancer, kidney cancer, and specific types of thyroid cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Sorafenib 200 mg works by blocking multiple protein kinases involved in cancer-cell growth and the formation of new blood vessels, a process known as angiogenesis. By inhibiting these signalling pathways, it reduces the tumour’s blood supply and helps slow the growth and spread of cancer cells.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.